Markets › United States › NAS › FBIOP

Fortress Biotech, Inc.

NAS:FBIOPHealthcare

$16.42−1.67%At closeAt close · Wed 21 Oct · ≈ AED 60.30 · Market cap $62.37M · Next earnings Mon 16 Nov

Ratio	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	Current · undated	YoY
Gross margin	68.0%	53.4%	59.4%	72.9%	63.8%	66.9%	—	—
Operating margin	−206.7%	−274.1%	−268.8%	−168.4%	−191.4%	−111.0%	−111.0%	+0.0 pts
Net margin	−102.0%	−94.1%	−114.3%	−71.7%	−79.8%	10.8%	10.8%	+0.0 pts
EBITDA margin	−192.6%	−212.5%	−255.7%	−160.6%	−181.2%	−31.9%	—	—
Return on equity	−46.4%	−59.5%	−207.5%	−269.0%	−202.3%	13.7%	11.0%	−2.7 pts
Return on assets	−14.0%	−16.3%	−29.4%	−36.2%	−31.9%	3.7%	3.7%	+0.0 pts
Return on capital employed	−33.5%	−63.8%	−122.2%	−172.3%	−151.6%	−51.7%	—	—
Debt / equity	0.9×	0.7×	3.1×	3.8×	3.3×	1.5×	1.2×	−19.8%
Debt / assets	26.7%	18.9%	43.3%	50.5%	52.7%	40.0%	—	—
Interest coverage	−6.2×	−12.3×	−14.9×	−11.4×	−11.1×	−8.1×	—	—
Current ratio	5.1×	3.4×	1.8×	1.4×	1.3×	2.5×	2.5×	+0.0%
Quick ratio	5.1×	3.3×	1.7×	1.3×	1.1×	2.3×	—	—
Cash ratio	4.5×	3.0×	1.4×	1.0×	0.8×	1.6×	1.6×	+0.0%
Asset turnover	0.1×	0.2×	0.3×	0.5×	0.4×	0.3×	—	—
Inventory turnover	10.4×	3.3×	2.2×	2.2×	1.4×	2.2×	—	—
Receivables turnover	1.8×	2.9×	2.7×	5.5×	5.5×	2.1×	—	—
Dividend payout	−14.5%	−13.6%	−10.1%	−14.5%	−10.2%	9.7%	—	—